Related Experiment Video
Updated: May 16, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Trabectedin-Associated Myocardial Infarction With Nonobstructive Coronary Arteries
Srikiran Dasari1, Eduardo Alfredo Aviles1, Brijesh Patel2
1Division of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Background:
Trabectedin is a marine-derived alkylating agent used to treat soft tissue sarcomas.
Case Summary:
We present a case of myocardial infarction with nonobstructive coronary arteries (MINOCA) in a 58-year-old man with no prior cardiac history who was receiving trabectedin for metastatic liposarcoma. Initial work-up revealed elevated high-sensitivity troponin, unremarkable electrocardiogram and echocardiogram, and mild nonobstructive coronary disease on coronary angiography. The patient's chest discomfort recurred days after another chemotherapy cycle, and it was hypothesized that coronary vasospasm produced his symptoms. Prophylactic amlodipine and isosorbide mononitrate were administered around subsequent cycles, with complete resolution of symptoms.
Discussion:
Recurrent episodes of acute coronary syndrome after trabectedin infusions that resolved with vasodilator pretreatment supported trabectedin-induced coronary vasospasm as the mechanism of MINOCA in this patient. This is to our knowledge the first reported such case with trabectedin.
Take-Home Message:
Patients who develop trabectedin-associated MINOCA may benefit from pretreatment with anti-vasospastic antianginals to allow for safe continuation of therapy.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina II: Classification
Imaging Studies for Cardiovascular System V: CT
Coronary Artery Disease III: Clinical Manifestations
